نتایج جستجو برای: Interferon

تعداد نتایج: 68447  

Journal: :caspian journal of internal medicine 0
maryam mobini

background: interferons (ifns) are common therapeutics for several diseases such as viral hepatitis, multiple sclerosis and malignancy. a variety of autoimmune related side effects have been observed during ifn therapy. rare cases of myopathy, polymyositis or dermatomyositis have been reported during therapy with high doses of ifn^5. case presentation: in this report, we describe a case with se...

قوتی, شاهرخ, میرحسینی, ضیاءالدین, پزشکیان, زهرا,

Background and purpose: Interferon beta-1b recombinant protein is used for reducing the relapse rate and treatment in patients with Multiple sclerosis (MS). In this study, phylogenetic and in silico analysis of interferon beta-1b were conducted by servers and bioinformatics tools to predict its structural potential. Materials and methods: Physiological and physico-chemical characteristics of...

Background: Interferon (IFN) are small proteins that belong to the cytokine family and may interfere with viral infections and some cancers. There are many studies focused on the PEGylated interferon’s bioactivity. In this study, we used solid lipid nanoparticles (SLNs) to produce new drug formulations, with the aim of reducing costs, increasing effectiveness, and also reducing side effects, an...

A Shokoohi SM Alavian

α-Interferon is an antiviral agent used in treatment of chronic hepatitis B. Triggering of the underlying autoimmune disease or exacerbation of pre-existing auto immune disease is documented with α-interferon, but there are few reports about occurrence of autoimmune disorders such as systemic lupus erythematosus, Vitiligo, hypo and hyperthyroidism after administration of α-interferon in the lit...

Journal: :gastroenterology and hepatology from bed to bench 0
sara ashtari mohsen vahedi mohamad amin pourhoseingholi phd. asma pourhoseingholi azadeh safaee bijan moghimi-dehkordi

aim : the objective of this study was to estimate the average cost of diagnosis and treatment of hepatitis c among patients based on their treatment regime, during the one course of treatment and six-month after stopping that. background : hepatitis c virus (hcv) infection is a major cause of liver-related morbidity and mortality worldwide and a major public health problem. patients and methods...

Journal: :hepatitis monthly 0
yue-li xiong department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china fen liu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china fen liu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china dazhi zhang department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china hong ren department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china peng hu department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china; department of infectious diseases, institute for viral hepatitis, key laboratory of molecular biology for infectious diseases, ministry of education, second affiliated hospital of chongqing medical university, chongqing, china. tel: +86-2363693289, fax: +86-2363703790

background after treatment cessation, a high prevalence of relapse was reported in chronic hepatitis b (chb) patients in china, especially in nucleot(s)ide analogues (nucs)-experienced patients. re-treatment for these patients remains unsolved. objectives this study aims to evaluate the efficacy of pegylated interferon in hbeag positive patients with exposure to antiviral therapy. patients and ...

Journal: :acta medica iranica 0
mehrdokht mazdeh department of neurology, farshchian hospital, hamadan university of medical sciences, hamadan, iran. saeed afzali department of internal medicine, farshchian hospital, hamadan university of medical sciences, hamadan, iran. mahmood reza jaafari department of radiology, farshchian hospital, hamadan university of medical sciences, hamadan, iran.

we aimed to compare the therapeutic effect of avonex (av), betaferon (be) & rebif (re) on the expanded disability status scale (edss) in multiple sclerosis (ms). ninety patients referring to farshchian hospital were entered in this study. the patients were divided into three equal groups: group 1 received av, group 2 received re and group 3 received be, and after 24 months, comparison was done ...

Journal: :iranian journal of neurology 0
payam khomand department of neurology, school of medicine, tohid hospital, kurdistan university of medical sciences, sanandaj, iran ghobad moradi social determinants of health research center, department of epidemiology and biostatistics, school of medicine, kurdistan university of medical sciences, sanandaj, iran setareh abtahi department of neurology, school of medicine, tohid hospital, kurdistan university of medical sciences, sanandaj, iran behrooz ahsan department of neurology, school of medicine, tohid hospital, kurdistan university of medical sciences, sanandaj, iran

abstract introduction:  this study was performed to compare the effects of low-dose interferon beta-1(cinnovex,30 mcg) and high-dose interferon beta-1(rebif,44 mcg) on the reduction of the number and size of plaques in magnetic resonance imaging (mri) in patients with multiple sclerosis (ms). methods and materials: this historical cohort study, which was performed in 2014 in sanandaj (western p...

Journal: :hepatitis monthly 0
zhifeng lin department of epidemiology and health statistics, school of public health, guangdong pharmaceutical university, guangzhou, china junguo zhang department of epidemiology and health statistics, school of public health, guangdong pharmaceutical university, guangzhou, china xiaomin ma department of epidemiology and health statistics, school of public health, guangdong pharmaceutical university, guangzhou, china shuo yang department of epidemiology and health statistics, school of public health, guangdong pharmaceutical university, guangzhou, china nana tian department of epidemiology and health statistics, school of public health, guangdong pharmaceutical university, guangzhou, china xinqi lin department of epidemiology and health statistics, school of public health, guangdong pharmaceutical university, guangzhou, china

conclusions this study supports the idea that the ifnl3 gene is an important predictor of the response of chb patients to ifn therapy. results nine studies of 1602 chb patients receiving ifn treatment were included. under the random-effects model, patients expressing the variant rs12980275 showed a significantly increased response to ifn therapy (or = 2.85; 95% ci = 1.14 - 4.60). in the subgrou...

Journal: :hepatitis monthly 0
ehsan aminizadeh department of gastroenterology, tehran university of medical sciences, tehran, ir iran; department of health management and economics, school of public health, tehran university of medical sciences, tehran, ir iran; department of gastroenterology, tehran university of medical sciences, tehran, ir iran. tel: +98-2166831748, fax: +98-2188958935 seyed moayyed alavian research center for gastroenterology and liver disease, baqiyatallah university of medical sciences, tehran, ir iran ali akbari sari department of health management and economics, school of public health, tehran university of medical sciences, tehran, ir iran nasser ebrahimi daryani department of gastroenterology, tehran university of medical sciences, tehran, ir iran bita behnava research center for gastroenterology and liver disease, baqiyatallah university of medical sciences, tehran, ir iran

conclusions compared with monotherapy, adding ribavirin to treatment is more effective in removing hepatitis c virus from the bloodstream in patients with thalassemia, it is also more effective in reducing the relapse rate after treatment. except the increase in blood transfusion, there was no significant increase in side effects followed by adding ribavirin. results three randomized clinical t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید